Neogen Chemicals Limited (Neogen) (NSE: NEOGEN, BSE: 542665) is a Thane, Maharashtra-based company in the Custom Synthesis and Specialty CDMO industry. With a market capitalisation of ₹7,465 Cr, it ranks #688 by market cap among the 6,137 Indian listed companies on FinBizNet, and #2 of 13 in Custom Synthesis and Specialty CDMO. At ₹2,173.70 (as of 25 Oct 2026), the share price is 21.9% below its 52-week high of ₹2,785.00 and 124.9% above its 52-week low of ₹966.70. The share price is up 45.2% over one year and up 5.4% over three months.
| Current Price | ₹2,173.70 |
|---|---|
| Market Cap | ₹7,465 Cr |
| NSE Symbol | NEOGEN |
| BSE Code | 542665 |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Custom Synthesis and Specialty CDMO |
| P/E Ratio | 227.6 |
| Return on Equity | 3.58% |
| Return on Assets | 2.95% |
| 52-Week Range | ₹966.70 – ₹2,785.00 |
| 1-Year Price Change | +45.2% |
| 3-Month Price Change | +5.4% |
| Beta (1Y) | 0.72 |
| Dividend Yield | 0.04% |
| Headquarters | Thane, Maharashtra |
| Website | www.neogenchem.com |
| Revenue | ₹250 Cr |
|---|---|
| Net Profit | ₹17 Cr |
| Net Margin | 6.8% |
| EPS (Basic) | ₹6.29 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride borate, lithium diisopropylamide, lithium tri-(t-butoxy) aluminium hydride, hexyl lithium, methyl lithium, and phenyl lithium. The company also provides inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; advance intermediates; and chemistries, such as alkylation, amination, oxidation, dehalogenation, silylation, anhydrous HF and HBr reactions, suzuki co
1. Manufacturing of Speciality Chemicals-This segment manufacturers of bromine and lithium based specialty chemicals. It offers organic chemicals, such as alkyl bromide compounds, dibromo alkane compounds, and bromo chloro alkanes; specialty chemical compounds; grignard reagents; advance intermediates; inorganic bromine compounds; and lithium salts. The company also provides custom synthesis and contract manufacturing services.
1. Manufacturing of Speciality Chemicals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Anupam Rasayan India Ltd | ₹13,389 Cr | 73.6 | 5.76% | ₹655 Cr | -2.2% |
| Neogen Chemicals Limited (Neogen) | ₹7,465 Cr | 227.6 | 3.58% | ₹250 Cr | +45.2% |
| Laxmi Organic Industries Ltd | ₹4,963 Cr | 59.9 | 4.08% | ₹968 Cr | -27.6% |
| Tatva Chintan Pharma Chem Ltd | ₹4,547 Cr | 105.8 | 5.53% | ₹217 Cr | +22.0% |
| Prasol Chemicals Limited | ₹4,476 Cr | 50.7 | — | ₹434 Cr | — |
| Paushak Ltd. | ₹2,046 Cr | 42.9 | 8.22% | ₹84 Cr | — |
| Sunshield Chemicals Ltd. | ₹906 Cr | 27.7 | 17.02% | — | +12.6% |
| Chemcon Speciality Chemicals Limited | ₹803 Cr | 33.4 | 4.80% | ₹65 Cr | -27.6% |
| Arvee Laboratories (India) Ltd | ₹249 Cr | 93.9 | 7.78% | ₹17 Cr | +17.6% |
Listed by market capitalisation. Ratios are shown for context only.
Neogen Chemicals Limited (Neogen) is trading at ₹2,173.70, with a market capitalisation of ₹7,465 Cr.
Neogen Chemicals Limited (Neogen) operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Custom Synthesis and Specialty CDMO).
Neogen Chemicals Limited (Neogen) has a P/E of 227.6 and a return on equity of 3.58%.
Neogen Chemicals Limited (Neogen) is listed on the NSE under the symbol NEOGEN and on the BSE under the scrip code 542665.
Neogen Chemicals Limited (Neogen)'s share price is up 45.2% over one year and up 5.4% over three months. Its 52-week range is ₹966.70 to ₹2,785.00.
In Q1 FY27, Neogen Chemicals Limited (Neogen) reported revenue of ₹250 Cr and net profit of ₹17 Cr, with basic EPS of ₹6.29 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.